Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | Unknown | — |
The patient missed second dose of Jynneos which was due on 25-Oct-2024, because could not get it anywhere.; Case reference number US-BN-2024-002796 is a spontaneous case report initially received from consumer via agency (reference number: USBAV24-3064) on 19-Nov-2024 and concerns a 72-year-old male patient. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient was vaccinated with the first dose of Jynneos vaccine (batch number: unknown), at an unknown dose, route or site of administration, for unknown indication. As reported, the patient missed second dose of Jynneos which was due on 25-Oct-2024, because could not get it anywhere (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccine. No further information was provided. Non-significant case correction performed for information received from VAERS on 06-Jan-2025 included additional reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241119-78de0f to US-BAVARIAN NORDIC A/S-US-BN-2024-002796, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A 72-year-old male patient was vaccinated with the first dose of Jynneos vaccine for unknown indication. As reported, the patient missed the second dose of Jynneos which was due on 25-Oct-2024, because could not get it anywhere, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Jynneos vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 72-year-old male patient was vaccinated with the first dose of Jynneos vaccine for unknown indication. As reported, the patient missed the second dose of Jynneos which was due on 25-Oct-2024, because could not get it anywhere, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Jynneos vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None